Free Trial

Cerus (CERS) Competitors

Cerus logo
$1.25 -0.09 (-6.72%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$1.30 +0.05 (+4.08%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CERS vs. STAA, OSUR, UTMD, ANIK, COO, WST, ALGN, MMSI, ICUI, and HAE

Should you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry.

Cerus vs.

STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

STAAR Surgical has higher revenue and earnings than Cerus. STAAR Surgical is trading at a lower price-to-earnings ratio than Cerus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$279.13M3.27-$20.21M-$1.44-12.81
Cerus$185.14M1.29-$37.49M-$0.10-12.50

STAAR Surgical presently has a consensus target price of $24.63, suggesting a potential upside of 33.47%. Cerus has a consensus target price of $3.50, suggesting a potential upside of 180.00%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cerus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

STAAR Surgical has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500.

In the previous week, STAAR Surgical had 11 more articles in the media than Cerus. MarketBeat recorded 13 mentions for STAAR Surgical and 2 mentions for Cerus. STAAR Surgical's average media sentiment score of 1.20 beat Cerus' score of 0.84 indicating that STAAR Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
9 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerus
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STAAR Surgical has a net margin of -6.44% compared to Cerus' net margin of -11.60%. STAAR Surgical's return on equity of -3.35% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical-6.44% -3.35% -2.67%
Cerus -11.60%-40.55%-11.12%

Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 53.92% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
289
53.92%
Underperform Votes
247
46.08%
CerusOutperform Votes
570
72.34%
Underperform Votes
218
27.66%

Summary

STAAR Surgical and Cerus tied by winning 9 of the 18 factors compared between the two stocks.

Get Cerus News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CERS vs. The Competition

MetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$238.95M$4.47B$5.35B$8.38B
Dividend YieldN/A43.64%5.22%4.10%
P/E Ratio-11.3629.4326.8419.71
Price / Sales1.2967.72391.39116.98
Price / CashN/A51.0838.2534.62
Price / Book4.316.236.794.50
Net Income-$37.49M$68.16M$3.23B$248.18M
7 Day PerformanceN/A18.33%4.07%1.14%
1 Month Performance-3.10%23.04%12.52%15.20%
1 Year Performance-32.43%20.61%16.83%6.56%

Cerus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CERS
Cerus
2.8923 of 5 stars
$1.25
-6.7%
$3.50
+180.0%
-32.4%$238.95M$185.14M-11.36290Positive News
Gap Up
STAA
STAAR Surgical
4.0742 of 5 stars
$20.27
+4.4%
$24.63
+21.5%
-56.6%$1.00B$279.13M-49.44960Analyst Forecast
Buyback Announcement
Gap Up
OSUR
OraSure Technologies
4.0312 of 5 stars
$2.67
+6.4%
$5.50
+106.0%
-48.0%$206.89M$185.83M17.80840Analyst Forecast
UTMD
Utah Medical Products
2.1592 of 5 stars
$54.02
+0.8%
N/A-22.4%$177.29M$39.27M13.68180Dividend Announcement
ANIK
Anika Therapeutics
4.1355 of 5 stars
$11.85
+1.8%
$21.33
+80.0%
-54.5%$169.94M$119.91M-1.78300Gap Up
COO
Cooper Companies
3.1303 of 5 stars
$84.44
+2.6%
$110.25
+30.6%
-18.0%$16.89B$3.93B43.3014,000Positive News
Upcoming Earnings
Analyst Upgrade
WST
West Pharmaceutical Services
4.5681 of 5 stars
$219.20
+2.9%
$332.50
+51.7%
-38.0%$15.75B$2.90B32.7710,700Trending News
Analyst Revision
ALGN
Align Technology
4.781 of 5 stars
$189.00
+3.9%
$241.25
+27.6%
-34.9%$13.84B$3.98B33.6923,200Positive News
MMSI
Merit Medical Systems
4.1455 of 5 stars
$98.73
+3.0%
$107.78
+9.2%
+17.2%$5.83B$1.39B48.406,850Trending News
Analyst Forecast
Insider Trade
Analyst Revision
ICUI
ICU Medical
4.7589 of 5 stars
$144.34
+4.4%
$192.67
+33.5%
+27.3%$3.55B$2.38B-31.5814,500Insider Trade
Gap Up
HAE
Haemonetics
4.3169 of 5 stars
$70.23
+3.0%
$97.89
+39.4%
-28.2%$3.53B$1.36B27.652,820Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:CERS) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners